IP Library › Assignment 032411/0131
Patent Assignment
Reel/Frame 032411/0131

Assignment of Assignor's Interest

Recorded: 2014-03-12 Pages: 2
Assignor
TECHNISCHE UNIVERSITAET DRESDEN
Executed: 2014-02-19
Assignee
GEMOAB MONOCLONALS GMBH
FIEDLERSTR. 36, DRESDEN, 01307, GERMANY
Covered Properties (2)
Anti-CD33 Antibodies and Use Thereof for Immunotargeting in Treating CD33-Associated Illnesses
Patent: 8,759,494 →
Application: 13/497,800 →
Publication: US 2012/0251554
Antibodies against prostate-specific stem cell antigen and use thereof
Patent: 9,200,078 →
Application: 14/129,933 →
Publication: US 2014/0134155
Related Assignments (6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 2, 2012
From: BACHMANN, MICHAEL; STAMOVA, SLAVA
To: TECHNISCHE UNIVERSITAET DRESDEN
Reel/Frame 028307/0601 →
Assignment of Assignor's Interest Dec 28, 2013
From: BACHMANN, MICHAEL
To: TECHNISCHE UNIVERSITAET DRESDEN
Reel/Frame 031855/0862 →
Change of Name Nov 23, 2021
From: GEMOAB MONOCLONALS GMBH
To: GEMOAB GMBH
Reel/Frame 058566/0170 →
Change of Name May 26, 2022
From: GEMOAB GMBH
To: AVENCELL EUROPE GMBH
Reel/Frame 060202/0628 →
Security Interest Jan 4, 2024
From: AVENCELL THERAPEUTICS, INC.
To: BXLS V - DIAMANT L.P., AS COLLATERAL AGENT
Reel/Frame 066026/0610 →
Release of Security Interest Oct 18, 2024
From: BXLS V – DIAMANT L.P.
To: AVENCELL THERAPEUTICS, INC.
Reel/Frame 068941/0187 →